These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33419885)

  • 1. Influenza virus infection increases ACE2 expression and shedding in human small airway epithelial cells.
    Schweitzer KS; Crue T; Nall JM; Foster D; Sajuthi S; Correll KA; Nakamura M; Everman JL; Downey GP; Seibold MA; Bridges JP; Serban KA; Chu HW; Petrache I
    Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 33419885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells.
    Heindl MR; Rupp A-L; Schwerdtner M; Bestle D; Harbig A; De Rocher A; Schmacke LC; Staker B; Steinmetzer T; Stein DA; Moulton HM; Böttcher-Friebertshäuser E
    J Virol; 2024 Apr; 98(4):e0010224. PubMed ID: 38470058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.
    Ziegler CGK; Allon SJ; Nyquist SK; Mbano IM; Miao VN; Tzouanas CN; Cao Y; Yousif AS; Bals J; Hauser BM; Feldman J; Muus C; Wadsworth MH; Kazer SW; Hughes TK; Doran B; Gatter GJ; Vukovic M; Taliaferro F; Mead BE; Guo Z; Wang JP; Gras D; Plaisant M; Ansari M; Angelidis I; Adler H; Sucre JMS; Taylor CJ; Lin B; Waghray A; Mitsialis V; Dwyer DF; Buchheit KM; Boyce JA; Barrett NA; Laidlaw TM; Carroll SL; Colonna L; Tkachev V; Peterson CW; Yu A; Zheng HB; Gideon HP; Winchell CG; Lin PL; Bingle CD; Snapper SB; Kropski JA; Theis FJ; Schiller HB; Zaragosi LE; Barbry P; Leslie A; Kiem HP; Flynn JL; Fortune SM; Berger B; Finberg RW; Kean LS; Garber M; Schmidt AG; Lingwood D; Shalek AK; Ordovas-Montanes J; ;
    Cell; 2020 May; 181(5):1016-1035.e19. PubMed ID: 32413319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression and
    Aguiar JA; Tremblay BJ; Mansfield MJ; Woody O; Lobb B; Banerjee A; Chandiramohan A; Tiessen N; Cao Q; Dvorkin-Gheva A; Revill S; Miller MS; Carlsten C; Organ L; Joseph C; John A; Hanson P; Austin RC; McManus BM; Jenkins G; Mossman K; Ask K; Doxey AC; Hirota JA
    Eur Respir J; 2020 Sep; 56(3):. PubMed ID: 32675206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
    Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
    Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.
    Xu J; Xu X; Jiang L; Dua K; Hansbro PM; Liu G
    Respir Res; 2020 Jul; 21(1):182. PubMed ID: 32664949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein.
    Heurich A; Hofmann-Winkler H; Gierer S; Liepold T; Jahn O; Pöhlmann S
    J Virol; 2014 Jan; 88(2):1293-307. PubMed ID: 24227843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
    Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
    Elife; 2020 May; 9():. PubMed ID: 32452762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells.
    Kimura H; Francisco D; Conway M; Martinez FD; Vercelli D; Polverino F; Billheimer D; Kraft M
    J Allergy Clin Immunol; 2020 Jul; 146(1):80-88.e8. PubMed ID: 32422146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the SARS-CoV-2
    Zhang H; Rostami MR; Leopold PL; Mezey JG; O'Beirne SL; Strulovici-Barel Y; Crystal RG
    Am J Respir Crit Care Med; 2020 Jul; 202(2):219-229. PubMed ID: 32432483
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
    Gkogkou E; Barnasas G; Vougas K; Trougakos IP
    Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.
    Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK
    Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
    Roehrich H; Yuan C; Hou JH
    Cornea; 2020 Dec; 39(12):1556-1562. PubMed ID: 32826650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.
    Gheblawi M; Wang K; Viveiros A; Nguyen Q; Zhong JC; Turner AJ; Raizada MK; Grant MB; Oudit GY
    Circ Res; 2020 May; 126(10):1456-1474. PubMed ID: 32264791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19.
    Dong M; Zhang J; Ma X; Tan J; Chen L; Liu S; Xin Y; Zhuang L
    Biomed Pharmacother; 2020 Nov; 131():110678. PubMed ID: 32861070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting TMPRSS2 in SARS-CoV-2 Infection.
    Baughn LB; Sharma N; Elhaik E; Sekulic A; Bryce AH; Fonseca R
    Mayo Clin Proc; 2020 Sep; 95(9):1989-1999. PubMed ID: 32861340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications.
    Davidson AM; Wysocki J; Batlle D
    Hypertension; 2020 Nov; 76(5):1339-1349. PubMed ID: 32851855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract.
    Ortiz ME; Thurman A; Pezzulo AA; Leidinger MR; Klesney-Tait JA; Karp PH; Tan P; Wohlford-Lenane C; McCray PB; Meyerholz DK
    EBioMedicine; 2020 Oct; 60():102976. PubMed ID: 32971472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.